阿姆洛迪平相关的血管:使用不成比例性和相互作用分析和病例评估进行综合药监测评估
Kannan Sridharan1, Gowri Sivaramakrishnan2
1Department of Pharmacology & Therapeutics, College of Medicine & Health Sciences, Arabian Gulf University, Manama P.O. Box 26671, Bahrain.
Journal of clinical medicine
|February 26, 2025
概括
阿姆洛迪平可能会增加血管风险,严重的胀状况,当单独使用或与某些血压药物一起使用时. 建议对患者进行密切监测,特别是在开始安洛迪平治疗时.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 药品安全 药品安全
背景情况:
- 阿姆洛迪平通常用于高血压,通常与氨酸-氨酸-阿尔多斯特系统抑制剂 (RAAS-i) 一起使用.
- 虽然RAAS-i已知是血管的原因,但amlodipine的独立或联合风险仍未得到充分研究.
研究的目的:
- 通过使用现实世界药监数据,评估阿姆洛迪平使用和血管之间的关联.
- 为了确定阿姆洛迪平和RAAS-i之间有关血管风险的潜在药物相互作用.
主要方法:
- 对大型不良事件数据库 (FDA不良事件报告系统) 的分析.
- 频率主义和贝叶斯统计方法用于信号检测的应用.
- 对已发表的病例报告进行系统审查,以评估因果关系.
主要成果:
- 与阿姆洛迪平单一治疗和特定的阿姆洛迪平-RAAS-i组合相关的血管的显著安全信号.
- 鉴定了与阿利斯基伦,ACE抑制剂 (例如,奎纳普利尔,贝纳泽普利尔) 和ARBs (例如,坎德沙坦,洛萨坦) 的相互作用.
- 病例报告的审查表明,在几个情况下,确定的或可能的因果关系,与典型的口腔/脸部胀和撤回后的恢复.
结论:
- 单独使用阿姆洛迪平或与某些RAAS-i一起使用,可能会增加血管风险.
- 对血管的临床警至关重要,特别是在阿姆洛迪平治疗开始时.
- 需要进一步的前性研究来证实发现并探索机制.
相关概念视频
Pharmacovigilance
764
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
764
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
452
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
452
Antihypertensive Drugs: Angiotensin II Receptor Blockers
568
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
568
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
437
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
437
Antihypertensive Drugs: Direct Renin Inhibitors
469
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
469
Local Anesthetics: Adverse Effects
385
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
385


